Literature DB >> 3130986

Fibrin-fibronectin compounds in human ovarian tumor ascites and their possible relation to the tumor stroma.

O Wilhelm1, R Hafter, E Coppenrath, M A Pflanz, M Schmitt, R Babic, R Linke, W Gössner, H Graeff.   

Abstract

Covalently linked heterogeneous fibrin-fibronectin compounds were detected in ascitic fluid of 31 patients with advanced ovarian cystadenocarcinoma by means of enzyme-linked immunosorbent assay techniques, immunoaffinity chromatography, and Western blot analysis. Deposition of fibrin and fibronectin could also be demonstrated immunohistochemically in Carnoy-fixed tissue sections. Fibrin and fibronectin were found in the tumor stroma within tumor nests and more prominently in stroma surrounding the tumor nests. The association of fibrin and fibronectin was especially pronounced in the stroma surrounding the tumor islands. Fibronectin was also found to be associated with stroma cells. Areas within the tumor stroma showed superimposed staining for both fibrin and fibronectin supporting the assumption that the covalently linked fibrin-fibronectin conjugates found in ascitic fluid may stem from the provisional tumor stroma by proteolytic release.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3130986

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  14 in total

1.  Targeting Fibronectin for Cancer Imaging and Therapy.

Authors:  Zheng Han; Zheng-Rong Lu
Journal:  J Mater Chem B       Date:  2016-12-01       Impact factor: 6.331

2.  Syndecan-1 in breast cancer stroma fibroblasts regulates extracellular matrix fiber organization and carcinoma cell motility.

Authors:  Ning Yang; Rachel Mosher; Songwon Seo; David Beebe; Andreas Friedl
Journal:  Am J Pathol       Date:  2010-12-23       Impact factor: 4.307

3.  A tumor-penetrating peptide enhances circulation-independent targeting of peritoneal carcinomatosis.

Authors:  Kazuki N Sugahara; Pablo Scodeller; Gary B Braun; Tatiana Hurtado de Mendoza; Chisato M Yamazaki; Michael D Kluger; Joji Kitayama; Edwin Alvarez; Stephen B Howell; Tambet Teesalu; Erkki Ruoslahti; Andrew M Lowy
Journal:  J Control Release       Date:  2015-06-11       Impact factor: 9.776

Review 4.  Mechanisms and Targets Involved in Dissemination of Ovarian Cancer.

Authors:  Ulrich H Weidle; Fabian Birzele; Gwendlyn Kollmorgen; Rüdiger Rueger
Journal:  Cancer Genomics Proteomics       Date:  2016 11-12       Impact factor: 4.069

5.  Urokinase (uPA) and its inhibitor PAI-1 are strong and independent prognostic factors in node-negative breast cancer.

Authors:  F Jänicke; M Schmitt; L Pache; K Ulm; N Harbeck; H Höfler; H Graeff
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

Review 6.  EGF-receptor regulation of matrix metalloproteinases in epithelial ovarian carcinoma.

Authors:  Laurie G Hudson; Natalie M Moss; M Sharon Stack
Journal:  Future Oncol       Date:  2009-04       Impact factor: 3.404

7.  Antisense inhibition of urokinase reduces spread of human ovarian cancer in mice.

Authors:  O Wilhelm; M Schmitt; S Höhl; R Senekowitsch; H Graeff
Journal:  Clin Exp Metastasis       Date:  1995-07       Impact factor: 5.150

8.  Mesothelial cells promote early ovarian cancer metastasis through fibronectin secretion.

Authors:  Hilary A Kenny; Chun-Yi Chiang; Erin A White; Elizabeth M Schryver; Mohammed Habis; Iris L Romero; Andras Ladanyi; Carla V Penicka; Joshy George; Karl Matlin; Anthony Montag; Kristen Wroblewski; S Diane Yamada; Andrew P Mazar; David Bowtell; Ernst Lengyel
Journal:  J Clin Invest       Date:  2014-09-09       Impact factor: 14.808

9.  Calcium Mobilization and Inhibition of Akt Reduced the Binding of PEO-1 Cells to Fibronectin.

Authors:  Seda Mehtap Sari Kiliçaslan; Aysun Ayrim; Elif Apaydin; Zerrin Incesu
Journal:  Turk J Pharm Sci       Date:  2018-04-02

Review 10.  Personalized models of heterogeneous 3D epithelial tumor microenvironments: Ovarian cancer as a model.

Authors:  Eric N Horst; Michael E Bregenzer; Pooja Mehta; Catherine S Snyder; Taylor Repetto; Yang Yang-Hartwich; Geeta Mehta
Journal:  Acta Biomater       Date:  2021-04-30       Impact factor: 10.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.